WHO Expert Committee on Specifications for Pharmaceutical Preparations Fifty-third report

4. Guidelines on heating, ventilation and air-conditioning systems for non-sterile pharmaceutical

products. In: WHO Expert Committee on Specifications for Pharmaceutical Preparations, fifty-
second report. Geneva: World Health Organization; 2018: Annex 8 (WHO Technical Report Series,
No. 1010; http://apps.who.int/medicinedocs/documents/s23455en/s23455en.pdf, accessed 9
February 2019).
5. WHO good manufacturing practices: water for pharmaceutical use. In: WHO Expert Committee
on Specifications for Pharmaceutical Preparations, forty-sixth report. Geneva: World Health
Organization; 2012: Annex 2 (WHO Technical Report Series, No. 970; Geneva, World Health
Organization 2012 (WHO Technical Report Series, No. 970; http://apps.who.int/medicinedocs/
documents/s19464en/s19464en.pdf, accessed 11 February 2019).
6. World Health Organization. Quality assurance of pharmaceuticals. WHO guidelines, good
practices, related regulatory guidance and GXP training materials. CD-ROM, update 2018 (http://
digicollection.org/whoqapharm/, accessed 8 February 2019).
7. Guidance on good data and record management practices. In: WHO Expert Committee on
Specifications for Pharmaceutical Preparations, fiftieth report. Geneva: World Health Organization;
2016: Annex 5 (WHO Technical Report Series, No. 966; https://www.who.int/medicines/
publications/pharmprep/WHO_TRS_996_annex05.pdf, accessed 8 February 2019).
8. WHO guidelines on quality risk management. In: WHO Expert Committee on Specifications for
Pharmaceutical Preparations, forty-seventh report. Geneva: World Health Organization; 2013:
Annex 2 (WHO Technical Report Series, No. 981; https://www.who.int/medicines/areas/quality_
safety/quality_assurance/Annex2TRS-981.pdf, accessed 8 February 2019).
WHO Technical Report Series, No. 1019, 2019

134